S. 4472 · 119th Congress · Health
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Reauthorizes federal programs accelerating access to therapies for amyotrophic lateral sclerosis patients. AI-read
What it does
The Congressional Research Service hasn’t published a summary of this bill yet. Summaries usually follow within a few weeks of introduction.
Roll call votes
No recorded roll call votes on this bill. Most bills never get one; many pass by voice vote or unanimous consent, or stay in committee.
Latest action
Aug 10, 2026 · Held at the desk.